- Catalog ingredients or strategy
- Formula selected through consultation
- Provider
- Musely
- Finished-product status
- Provider-described compounded prescription
- Source date
- October 8, 2026
What is being prescribed?
The current provider page describes an estriol-containing cream positioned around firmness and the appearance of aging skin. A consultation determines the actual formulation. This is a different approach from the tretinoin-focused Anti-Aging Cream, despite the similarity of the names.[source]
What supports the claims?
Compounded finished drugs are not FDA-approved. This research did not verify an independent trial establishing that the exact Musely cream outperforms alternatives. Provider-reported improvements should not be treated as the same thing as a randomized comparison.[source]
The detail that changes the comparison
The page advertised $36 per month for a two-month supply, corresponding to $72 for that supply before applicable extras. Obtain the consultation fee, renewal cadence and quantity. A current promotion or different plan may have its own conditions.[source]
Questions for the consultation
Discuss relevant medical history and other hormone exposure with the clinician. Do not infer universal suitability or absence of systemic effects from the topical route. The prescriber should explain the intended benefit, uncertainty and a plan for reassessment.
Relevant alternatives
CoreAge Rx Time Out is a comparison within the estriol-containing category. A reader deciding between this and a retinoid should first discuss the different ingredient strategies, rather than deciding that two products with aging-related names perform the same medical role.
Your questions, answered
Is this a moisturizer without prescription considerations?
No. The provider describes a prescription product containing estriol. Its medical suitability and use should be discussed with the prescribing clinician.
Was this cream tested by the publication?
No. This is a source-based review, without hands-on application, laboratory testing or independent medical review. Provider statements and broader ingredient evidence are identified separately.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- Musely — The Aging Repair CreamProduct page; provider-reported outcomes are not independent comparative trials
- FDA — Compounding and the FDA: Questions and AnswersCompounded drugs are not FDA-approved; oversight and evidence limitations